Exact Mass: 482.2199
Exact Mass Matches: 482.2199
Found 500 metabolites which its exact mass value is equals to given mass value 482.2199
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2-Oxokanamycin
A kanamycin obtained by dehydrogenation at position 2 of kanamycin A.
3'-Hydroxy-T2 Toxin
3-Hydroxy-T2 Toxin is a mycotoxin from Fusarium sporotrichiella poae. It is a metabolite of T2 Toxin. It is a potential cereal contaminant. Mycotoxin from Fusarium sporotrichiella poae. Metabolite of T2 Toxin. Potential cereal contaminant D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
Sodium humate
It is used as a food additive .
Gedunin
A natural product found in Azadirachta indica. Gedunin is a pentacyclic triterpenoid natural product found particularly in Azadirachta indica and Cedrela odorata. It has a role as an antimalarial, an antineoplastic agent, a Hsp90 inhibitor and a plant metabolite. It is a limonoid, an acetate ester, an epoxide, an enone, a member of furans, a pentacyclic triterpenoid, an organic heteropentacyclic compound and a lactone. Gedunin is a natural product found in Azadirachta indica, Cedrela odorata, and other organisms with data available. A pentacyclic triterpenoid natural product found particularly in Azadirachta indica and Cedrela odorata.
1-<4-O-(2-hydroxy-1-hydroxymethylethyl)-3,5-dimethoxyphenyl>-2-<4-(1-propanol)-3-methoxyphenyl>-propane-1,3-diol|1-[4-O-(2-hydroxy-1-hydroxymethylethyl)-3,5-dimethoxyphenyl]-2-[4-(1-propanol)-3-methoxyphenyl]-propane-1,3-diol
(7R,8R)-4-O-(glycer-2-yl)-7,9,9-trihydroxy-3,5,3-trimethoxy-8-O-4-neolignan
(15S*,17R*)-17-acetoxy-3,3-dioxo-1,11:14,5:15,17-trioxy-3(4->18)-abeo-1-nor-brevia-4(18),12,4-triene|brevione E
10-acetoxyvaltrathydrin|10-acetyloxyvaltrate hydrin
17beta-hydroxy-1,2alpha-epoxyazadiradione|1alpha,2alpha-epoxy-17beta-hydroxyazadiradione
1,3,5,6-tetrahydroxy-4-(3-hydroxy-3-methylbutyl)-7,8-di-(3-methyl-2-butenyl)xanthone
withahisolide I|[(20S,22R,24R,25S)-5alpha,24,25-trihydroxy-17(13?18)-abeo-ergost-2,13,15,17-tetraene-1,26-dione]
1alpha,6alpha-diacetoxy-5alpha,12alpha,7beta,14beta-tetrahydroxycass-13(15)-en-16,12-olide|neocaesalpin MR
(6aR,9S,9aS)-3-[(4S)-4-hydroxy-2-methyl-6-oxocyclohexyl]-6a-methyl-9-[(2S)-2-methyloctanoyl]-9,9adihydro-6H-furo[2,3-h]isochromene-6,8(6aH)-dione|cohaerin C
withahisolide C|[(20S,22R,24S,25S,26R)-13beta,14beta:22,26:24,25-triepoxy-5alpha,26-dihydroxy-17(13?18)-abeo-5alpha-ergost-2,7-diene-1,6-dione]
6-O-(8-Hydroxy-2,6-dimethyl-2,6-octadienoyl)(E,E-)-2-(3,4-Dihydroxyphenyl)ethyl beta-D-glucopy-ranoside
(6S,Ra)-2-methylbut-2-enoic acid 2,3,10,11,12-pentamethoxy-6-methyl-7-methylene-5,6,7,8-tetrahydrodibenzo[a,c]cycloocten-1-yl ester|neglschisandrin B
2-[4-(beta-D-glucopyranosyloxy)-3-hydroxy-2,5-bis(3-methylbut-2-en-1-yl)phenyl]-2-hydroxyacetic acid|sabphenoside A
(7S,8R)-4-O-(glycer-2-yl)-7,9,9-trihydroxy-3,3,5-trimethoxy-8-O-4-neolignan
[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 7-methyloctanoate
Ala His Gln Gln
Ala Met Val Tyr
Ala Met Tyr Val
Ala Gln His Gln
Ala Gln Gln His
Ala Val Met Tyr
Ala Val Tyr Met
Ala Tyr Met Val
Ala Tyr Val Met
Cys Phe Ile Thr
Cys Phe Leu Thr
Cys Phe Thr Ile
Cys Phe Thr Leu
Cys Ile Phe Thr
Cys Ile Thr Phe
Cys Leu Phe Thr
Cys Leu Thr Phe
Cys Thr Phe Ile
Cys Thr Phe Leu
Cys Thr Ile Phe
Cys Thr Leu Phe
Cys Val Val Tyr
Cys Val Tyr Val
Cys Tyr Val Val
Glu His Pro Thr
Glu His Thr Pro
Glu Pro His Thr
Glu Pro Thr His
Glu Thr His Pro
Glu Thr Pro His
Phe Cys Ile Thr
Phe Cys Leu Thr
Phe Cys Thr Ile
Phe Cys Thr Leu
Phe Gly Pro Tyr
Phe Gly Tyr Pro
Phe Ile Cys Thr
Phe Ile Thr Cys
Phe Leu Cys Thr
Phe Leu Thr Cys
Phe Met Ser Val
Phe Met Val Ser
Phe Pro Gly Tyr
Phe Pro Tyr Gly
Phe Ser Met Val
Phe Ser Val Met
Phe Thr Cys Ile
Phe Thr Cys Leu
Phe Thr Ile Cys
Phe Thr Leu Cys
Phe Val Met Ser
Phe Val Ser Met
Phe Tyr Gly Pro
Phe Tyr Pro Gly
Gly Phe Pro Tyr
Gly Phe Tyr Pro
Gly His Asn Arg
Gly His Arg Asn
Gly Ile Met Tyr
Gly Ile Tyr Met
Gly Leu Met Tyr
Gly Leu Tyr Met
Gly Met Ile Tyr
Gly Met Leu Tyr
Gly Met Tyr Ile
Gly Met Tyr Leu
Gly Asn His Arg
Gly Asn Arg His
Gly Pro Phe Tyr
Gly Pro Tyr Phe
Gly Arg His Asn
Gly Arg Asn His
Gly Tyr Phe Pro
Gly Tyr Ile Met
Gly Tyr Leu Met
Gly Tyr Met Ile
Gly Tyr Met Leu
Gly Tyr Pro Phe
His Ala Gln Gln
His Glu Pro Thr
His Glu Thr Pro
His Gly Asn Arg
His Gly Arg Asn
His Met Pro Val
His Met Val Pro
His Asn Gly Arg
His Asn Asn Val
His Asn Arg Gly
His Asn Val Asn
His Pro Glu Thr
His Pro Met Val
His Pro Thr Glu
His Pro Val Met
His Gln Ala Gln
His Gln Gln Ala
His Arg Gly Asn
His Arg Asn Gly
His Thr Glu Pro
His Thr Pro Glu
His Val Met Pro
His Val Asn Asn
His Val Pro Met
Ile Cys Phe Thr
Ile Cys Thr Phe
Ile Phe Cys Thr
Ile Phe Thr Cys
Ile Gly Met Tyr
Ile Gly Tyr Met
Ile Met Gly Tyr
Ile Met Tyr Gly
Ile Ser Thr Tyr
Ile Ser Tyr Thr
Ile Thr Cys Phe
Ile Thr Phe Cys
Ile Thr Ser Tyr
Ile Thr Tyr Ser
Ile Tyr Gly Met
Ile Tyr Met Gly
Ile Tyr Ser Thr
Ile Tyr Thr Ser
Leu Cys Phe Thr
Leu Cys Thr Phe
Leu Phe Cys Thr
Leu Phe Thr Cys
Leu Gly Met Tyr
Leu Gly Tyr Met
Leu Met Gly Tyr
Leu Met Tyr Gly
Leu Ser Thr Tyr
Leu Ser Tyr Thr
Leu Thr Cys Phe
Leu Thr Phe Cys
Leu Thr Ser Tyr
Leu Thr Tyr Ser
Leu Tyr Gly Met
Leu Tyr Met Gly
Leu Tyr Ser Thr
Leu Tyr Thr Ser
Met Ala Val Tyr
Met Ala Tyr Val
Met Phe Ser Val
Met Phe Val Ser
Met Gly Ile Tyr
Met Gly Leu Tyr
Met Gly Tyr Ile
Met Gly Tyr Leu
Met His Pro Val
Met His Val Pro
Met Ile Gly Tyr
Met Ile Tyr Gly
Met Leu Gly Tyr
Met Leu Tyr Gly
Met Pro His Val
Met Pro Val His
Met Ser Phe Val
Met Ser Val Phe
Met Val Ala Tyr
Met Val Phe Ser
Met Val His Pro
Met Val Pro His
Met Val Ser Phe
Met Val Tyr Ala
Met Tyr Ala Val
Met Tyr Gly Ile
Met Tyr Gly Leu
Met Tyr Ile Gly
Met Tyr Leu Gly
Met Tyr Val Ala
Asn Gly His Arg
Asn Gly Arg His
Asn His Gly Arg
Asn His Asn Val
Asn His Arg Gly
Asn His Val Asn
Asn Asn His Val
Asn Asn Val His
Asn Arg Gly His
Asn Arg His Gly
Asn Val His Asn
Asn Val Asn His
Pro Glu His Thr
Pro Glu Thr His
Pro Phe Gly Tyr
Pro Phe Tyr Gly
Pro Gly Phe Tyr
Pro Gly Tyr Phe
Pro His Glu Thr
Pro His Met Val
Pro His Thr Glu
Pro His Val Met
Pro Met His Val
Pro Met Val His
Pro Thr Glu His
Pro Thr His Glu
Pro Val His Met
Pro Val Met His
Pro Tyr Phe Gly
Pro Tyr Gly Phe
Gln Ala His Gln
Gln Ala Gln His
Gln His Ala Gln
Gln His Gln Ala
Gln Gln Ala His
Gln Gln His Ala
Arg Gly His Asn
Arg Gly Asn His
Arg His Gly Asn
Arg His Asn Gly
Arg Asn Gly His
Arg Asn His Gly
Ser Phe Met Val
Ser Phe Val Met
Ser Ile Thr Tyr
Ser Ile Tyr Thr
Ser Leu Thr Tyr
Ser Leu Tyr Thr
Ser Met Phe Val
Ser Met Val Phe
Ser Thr Ile Tyr
Ser Thr Leu Tyr
Ser Thr Tyr Ile
Ser Thr Tyr Leu
Ser Val Phe Met
Ser Val Met Phe
Ser Tyr Ile Thr
Ser Tyr Leu Thr
Ser Tyr Thr Ile
Ser Tyr Thr Leu
Thr Cys Phe Ile
Thr Cys Phe Leu
Thr Cys Ile Phe
Thr Cys Leu Phe
Thr Glu His Pro
Thr Glu Pro His
Thr Phe Cys Ile
Thr Phe Cys Leu
Thr Phe Ile Cys
Thr Phe Leu Cys
Thr His Glu Pro
Thr His Pro Glu
Thr Ile Cys Phe
Thr Ile Phe Cys
Thr Ile Ser Tyr
Thr Ile Tyr Ser
Thr Leu Cys Phe
Thr Leu Phe Cys
Thr Leu Ser Tyr
Thr Leu Tyr Ser
Thr Pro Glu His
Thr Pro His Glu
Thr Ser Ile Tyr
Thr Ser Leu Tyr
Thr Ser Tyr Ile
Thr Ser Tyr Leu
Thr Thr Val Tyr
Thr Thr Tyr Val
Thr Val Thr Tyr
Thr Val Tyr Thr
Thr Tyr Ile Ser
Val Ala Met Tyr
Val Ala Tyr Met
Val Cys Val Tyr
Val Cys Tyr Val
Val Phe Met Ser
Val Phe Ser Met
Val His Met Pro
Val His Asn Asn
Val His Pro Met
Val Met Ala Tyr
Val Met Phe Ser
Val Met His Pro
Val Met Pro His
Val Met Ser Phe
Val Met Tyr Ala
Val Asn His Asn
Val Asn Asn His
Val Pro His Met
Val Pro Met His
Val Ser Phe Met
Val Ser Met Phe
Val Val Cys Tyr
Val Val Tyr Cys
Val Tyr Ala Met
Val Tyr Cys Val
Val Tyr Met Ala
Val Tyr Val Cys
Tyr Ala Met Val
Tyr Ala Val Met
Tyr Cys Val Val
Tyr Phe Gly Pro
Tyr Phe Pro Gly
Tyr Gly Phe Pro
Tyr Gly Ile Met
Tyr Gly Leu Met
Tyr Gly Met Ile
Tyr Gly Met Leu
Tyr Gly Pro Phe
Tyr Ile Gly Met
Tyr Ile Met Gly
Tyr Leu Gly Met
Tyr Leu Met Gly
Tyr Met Ala Val
Tyr Met Gly Ile
Tyr Met Gly Leu
Tyr Met Ile Gly
Tyr Met Leu Gly
Tyr Met Val Ala
Tyr Pro Phe Gly
Tyr Pro Gly Phe
Tyr Thr Ser Leu
Tyr Val Ala Met
Tyr Val Cys Val
Tyr Val Met Ala
Tyr Val Val Cys
3'-Hydroxy-T 2
butyl prop-2-enoate,ethyl prop-2-enoate,2-methylidenebutanedioic acid,prop-2-enamide,prop-2-enenitrile
Tilorone dihydrochloride
C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist D007155 - Immunologic Factors > D007369 - Interferon Inducers D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents Tilorone dihydrochloride is an orally active interferon (IFN) inducer with broad-spectrum antiviral activities. Tilorone dihydrochloride possesses robust anti-Severe fever with thrombocytopenia syndrome virus (SFTSV) activity in vitro and in vivo through stimulation of host innate immunity. Tilorone dihydrochloride can penetrate the blood-brain barrier to activate HIF in the CNS[1][2][3].Tilorone dihydrochloride exhibits an inhibitory activity with EC50 of 230 nM against Ebola virus (EBOV)[4].
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester
(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol
N-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-2-[(1-ethyl-2-oxo-4-quinolinyl)oxy]acetamide
2-[3-[(2,6-Dimethylphenoxy)methyl]-4-methoxyphenyl]-3-[(5-methyl-2-furanyl)methyl]-1,2-dihydroquinazolin-4-one
[(E)-[(1R,4aR,4bS,8aS,10aS)-1-[2-[(2S)-2-hydroxy-5-oxo-2H-furan-3-yl]ethyl]-4b,8,8,10a-tetramethyl-1,3,4,4a,5,6,7,8a,9,10-decahydrophenanthren-2-ylidene]methyl] hydrogen sulfate
2-[(2S,4aR,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[3-(dimethylamino)propyl]acetamide
2-[(2S,4aS,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[3-(dimethylamino)propyl]acetamide
2-[(2S,4aR,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[3-(dimethylamino)propyl]acetamide
(2R,3R,3aS,9bS)-2-N-cyclobutyl-7-(2-fluorophenyl)-3-(hydroxymethyl)-6-oxo-1-N-propan-2-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-1,2-dicarboxamide
(1S,9R,10R,11R)-5-[3-(dimethylcarbamoyl)phenyl]-10-(hydroxymethyl)-6-oxo-12-(propan-2-ylcarbamoyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
2-[(2R,4aR,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[3-(dimethylamino)propyl]acetamide
2-[(2S,4aS,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[3-(dimethylamino)propyl]acetamide
(1R,9S,10S,11S)-5-[3-(dimethylcarbamoyl)phenyl]-10-(hydroxymethyl)-6-oxo-12-(propan-2-ylcarbamoyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
(2R)-2-[(4R,5S)-8-(2-cyclopropylethynyl)-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
[(1S)-7-methoxy-9-methyl-2-(4-oxanylmethyl)-1-(2-thiazolylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
(2S)-2-[(4R,5R)-8-(2-cyclopropylethynyl)-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5S)-8-(2-cyclopropylethynyl)-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5S)-8-(2-cyclopropylethynyl)-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-8-(2-cyclopropylethynyl)-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
2-[(2R,4aR,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[3-(dimethylamino)propyl]acetamide
2-[(2R,4aS,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-[3-(dimethylamino)propyl]acetamide
(2S,3S,3aR,9bR)-N2-cyclobutyl-7-(2-fluorophenyl)-3-(hydroxymethyl)-6-oxo-N1-propan-2-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-1,2-dicarboxamide
[(1R)-7-methoxy-9-methyl-2-(4-oxanylmethyl)-1-(2-thiazolylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
[(2R,3S,4S,5R,6R)-3,4,5-Trihydroxy-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 7-methyloctanoate
4-[(2R,5R)-3-hydroxy-5-[4-[[(2R)-2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoyl]oxy-6-methyloxan-2-yl]oxypentanoate
[(1S,2R,4aR,5S,7R,8S,8aR)-8-[(3aS,6aS)-3a,4,5,6a-tetrahydrofuro[2,3-b]furan-5-yl]-5-acetyloxy-1,2,3-trihydroxy-7,8-dimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-4a-yl]methyl acetate
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-tridec-9-enoate
3-Hydroxy-T2 Toxin
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
(1r,2s,15r,17s)-3,3,12,17,26-pentamethyl-4,18-dioxa-12,26-diazaheptacyclo[15.11.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0¹⁹,²⁸.0²⁰,²⁵]nonacosa-5(14),6,8,10,19(28),20,22,24-octaene-13,27-dione
methyl 2-[6-(furan-3-yl)-1,5,15,15-tetramethyl-8,14,17-trioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-16-yl]propanoate
(6ar,9s,9ar)-3-[(4s)-4-hydroxy-2-methyl-6-oxocyclohex-1-en-1-yl]-6a-methyl-9-[(2r)-2-methyloctanoyl]-9h,9ah-furo[2,3-h]isochromene-6,8-dione
(1s,2r,4s,7r,8s,9r,11s,12r,17r,19r)-7-(furan-3-yl)-1,9,12,16,16-pentamethyl-5,15-dioxo-3,6-dioxapentacyclo[9.8.0.0²,⁴.0²,⁸.0¹²,¹⁷]nonadec-13-en-19-yl acetate
7-(acetyloxy)-2,5,9-trihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-10-yl acetate
(1r,2r,15s,17s)-3,3,12,17,26-pentamethyl-4,18-dioxa-12,26-diazaheptacyclo[15.11.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0¹⁹,²⁸.0²⁰,²⁵]nonacosa-5(14),6,8,10,19(28),20,22,24-octaene-13,27-dione
6-(4,8-dimethylnona-3,7-dien-1-yl)-5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-2,3-dihydro-1-benzopyran-4-one
methyl 2-[(1s,2r,8r,9s,10r,13r)-2-(acetyloxy)-13-(furan-3-yl)-4,8,10,12-tetramethyl-7-oxo-16-oxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-4,11-dien-9-yl]acetate
7-(furan-3-yl)-1,8,12,16,16-pentamethyl-5,15-dioxo-3,6-dioxapentacyclo[9.8.0.0²,⁴.0²,⁸.0¹²,¹⁷]nonadec-13-en-19-yl acetate
16-acetyl-6-hydroxy-4-(1h-indol-3-ylmethyl)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one
(1s,2r,15r,17r)-3,3,12,17,26-pentamethyl-4,18-dioxa-12,26-diazaheptacyclo[15.11.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0¹⁹,²⁸.0²⁰,²⁵]nonacosa-5(14),6,8,10,19(28),20,22,24-octaene-13,27-dione
methyl 2-{2-[5-(acetyloxy)-3-(furan-3-yl)-3a-methyl-7-methylidene-hexahydroindeno[1,7a-b]oxiren-6-yl]-6,6-dimethyl-5-oxocyclohex-3-en-1-yl}acetate
3,3,12,17,26-pentamethyl-4,18-dioxa-12,26-diazaheptacyclo[15.11.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0¹⁹,²⁸.0²⁰,²⁵]nonacosa-5(14),6,8,10,19(28),20,22,24-octaene-13,27-dione
methyl 2-(2-{[6-(furan-3-yl)-7-methyl-11-methylidene-4-oxo-2,5-dioxatricyclo[5.4.0.0¹,³]undecan-10-yl]methyl}-2,6,6-trimethyl-5-oxocyclohex-3-en-1-yl)acetate
5,7,3′,4′-Tetramethoxyfl avone
{"Ingredient_id": "HBIN011196","Ingredient_name": "5,7,3\u2032,4\u2032-Tetramethoxyfl avone","Alias": "NA","Ingredient_formula": "C27H34N2O4S","Ingredient_Smile": "CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC)C=C2)C3=CC=CC=C3.OS(=O)(=O)[O-]","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41278","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}